Hamilton Point Investment Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.71M Sell
46,945
-1,006
-2% -$81.2K 0.52% 55
2026
Q1
$4.19M Sell
47,951
-22
-0% -$2.11K 0.65% 53
2025
Q4
$4.64M Buy
47,973
+150
+0.3% +$14.6K 0.71% 50
2025
Q3
$4.59M Buy
47,823
+448
+0.9% +$41.2K 0.72% 50
2025
Q2
$4.16M Sell
47,375
-616
-1% -$52.2K 0.69% 52
2025
Q1
$4.35M Buy
+47,991
New +$4.29M 0.78% 48

Other funds holding MDT

Hamilton Point Investment Advisors's MDT Position: Q2 2026 in Review

Hamilton Point Investment Advisors reduced its Medtronic (MDT) stake by 2.1% in Q2 2026, selling an estimated $81.2K and leaving 46,945 shares worth $3.71M. The position accounts for 0.52% of the portfolio, ranked #55.

Hamilton Point Investment Advisors first reported a position in MDT in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.64M in Q4 2025. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Hamilton Point Investment Advisors held 46,945 shares of Medtronic worth $3.71M as of Q2 2026.
  • Hamilton Point Investment Advisors sold 1,006 Medtronic shares in Q2 2026, an estimated $81.2K.
  • Medtronic made up 0.52% of Hamilton Point Investment Advisors's portfolio in Q2 2026, its #55 holding.
  • Hamilton Point Investment Advisors first reported a position in Medtronic in Q1 2025 and has held it in 6 quarters since.
  • Hamilton Point Investment Advisors's Medtronic position peaked at $4.64M in Q4 2025.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Hamilton Point Investment Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.